首页> 中文期刊> 《海南医学》 >血清sCD105及ADAM12应用于子痫前期筛查的研究进展

血清sCD105及ADAM12应用于子痫前期筛查的研究进展

         

摘要

Preeclampsia is a unique syndrome during pregnancy, and it is one of the important causes of maternal and perinatal death Many domcstic and foreign researches have been focusing on the pathogencsis of preeclampsia, and some theories have been proposed. However, its mechanism has not yet been clarified. It has been demonstrated by recent studies that a new anti-angiogenic protein, sCD105 and ADAM12s may be related to the pathogenesis ofpreeclampsia. This paper briefly introduces the research advances in relationship between sCD105 and ADAM12s to preeclampsia.%子痫前期是妊娠期特有的疾病,是孕产妇及围生儿死亡的重要原因之一.针对其发病原因,多年来国内外许多研究进行了各方面的探索,提出多种学说,但具体机制仍未明确.可溶性CD105(sCD105)及分泌性/可溶性解整合素-金属蛋白酶12(ADAM12)可能与子痫前期的发病机制相关,本文就这两者的研究进展作一综述.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号